Autobio

Autobio Diagnostics Co., Ltd (Hereinafter called Autobio) was founded in 1998, headquartered in National Eco & Tech Zone, Zhengzhou.

Autobio specialized in R & D, production, marketing, and service of clinical diagnostic products, especially covering immunoassay, microbiology, and biochemistry fields. Meanwhile, Autobio is also actively planning developments in the field of molecular diagnostics and provides a comprehensive solution for medical laboratories. Autobio was listed on Shanghai Stock Exchange on September 1st, 2016, and is the first IVD manufacturer listed on the main board in Shanghai, China. In 2019, Autobio’s revenue achieved USD 660 million.